Comparison the effect of Gonadotropin releasing hormone agonist administration versus vaginal Progesterone on serum progesterone in luteal phase in ovarian hyperstimulation and intrauterine insemination cycles in unexplained infertility
Not Applicable
- Conditions
- infertility.female infertility,unspecified
- Registration Number
- IRCT201205159762N1
- Lead Sponsor
- Vice-chancellor for research of Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 242
Inclusion Criteria
age<40 years old; FSH<10; normal Serum prolactin and thyroid function test; duration of infertility at least 1 year for each case; Normal hysterosalpigography in 6 month ago; normal semen analysis with WHO criteria (20 million sperm inml, 50%motility, 30% normal morphology); Regular menstruation cycles with midluteal progesterone>10ng/ml in previous cycles
exclusion criteria: previous ovarian surgery; Single ovary; polycystic ovaries on ultrasound examination; hypogonadotropic hypogonadism
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum progesterone in luteal phase. Timepoint: 10 days after intra uterine insemination. Method of measurement: blood sampling-ng/ml.
- Secondary Outcome Measures
Name Time Method Pregnancy. Timepoint: 14 days after intra uterine insemination. Method of measurement: blood sampling-iu/ml.